Showing 1661-1670 of 2314 results for "".
- DORC Launches New Range of EVA EquiPhaco Needles and Sleeveshttps://modernod.com/news/dorc-launches-new-range-of-eva-equiphaco-needles-and-sleeves/2477940/DORC announced the launch of a new range of EVA EquiPhaco needles and sleeves, which are designed to deliver superior ultrasound efficiency, improved anterior chamber stability, and easier sleeve positioning. T
- Johnson & Johnson Vision Donates $320K to Support Practitioners and Schools of Optometry Impacted by COVID-19https://modernod.com/news/johnson-johnson-vision-donates-320k-to-support-practitioners-and-schools-of-optometry-impacted-by-covid-19/2477924/As part of ongoing initiatives to help support eye care in the wake of COVID-19, Johnson & Johnson Vision announced donations to Optometry Cares, the charitable foundation of The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF). A
- Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Retinitis Pigmentosahttps://modernod.com/news/bionic-sight-llc-doses-first-patient-in-a-phase-1-2-clinical-trial-of-a-new-investigational-treatment-for-blindness-caused-by-retinitis-pigmentosa/2477902/Bionic Sight announced that it has dosed the first patient in the company’s phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with retinitis pigmentosa. This is an important step toward bringing BS01 forward as a treatment to enable patients with retinal degenerative dise
- AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doseshttps://modernod.com/news/astrazeneca-to-supply-europe-up-to-400-million-covid-19-vaccine-doses/2479514/AstraZeneca announced that it has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford’s COVID-19 experimental vaccine, with deliveries starting by the end of this year. CEO Pascal Soriot remarked that ̶
- Eversight Awarded Targeted Research Grant to Analyze COVID-19 Effects on Eye Donationhttps://modernod.com/news/eversight-awarded-targeted-research-grant-to-analyze-covid-19-effects-on-eye-donation/2477886/Eversight has been awarded an Eye Bank Association of America (EBAA) Targeted Research Grant to investigate COVID-19 testing of potential eye tissue donors and how COVID-19 infection affects the safety of eye tissues donated for sight-restoring transplants. Individuals known or suspected o
- New Data on the Pharmacokinetic Profile of Tepezza Reinforce the Labeled Dosing Regimenhttps://modernod.com/news/new-data-on-the-pharmacokinetic-profile-of-tepezza-reinforce-the-labeled-dosing-regimen/2477768/Horizon Therapeutics announced new data that provide important insights into the mechanisms of Tepezza (teprotumumab-trbw), illustrating its pharmacokinetic (PK) profile and supporting the dosing regimen established in the labeling for the treatment of Thyroid Eye Disease (TED). A separate abstra
- Ocular Therapeutix Announces First Patient Dosed in Phase 1 Clinical Trial of OTX-CSI For Treatment of Dry Eye Diseasehttps://modernod.com/news/ocular-therapeutix-announces-first-patient-dosed-in-phase-1-clinical-trial-of-otx-csi-for-treatment-of-dry-eye-disease/2477754/Ocular Therapeutix announced that it has dosed the first patients in its phase 1 clinical trial of OTX-CSI (cyclosporine intracanalicular insert) for the treatment of dry eye disease (DED). “We are pleased to be advancing OTX-CSI in the chronic treatment of dry eye disease,” Michael Goldst
- The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Millionhttps://modernod.com/news/the-allergan-foundation-doubles-its-covid-19-response-donations-to-4-0-million/2477733/Allergan announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community organizations responding to the COVID-19 pandemic. The new grants double The Allergan Foundation’s total COVID-19 donations to date, r
- Doximity Enters Telemedicine With Launch of Dialer Videohttps://modernod.com/news/doximity-enters-telemedicine-with-launch-of-dialer-video/2477732/Doximity announced the launch of Doximity Dialer Video, the company’s first telemedicine offering. With one click, Doximity Dialer Video lets doctors video call their patients, in an encrypted environment that complies with HIPAA privacy regulations. The new tool works with a doctor’s personal iO
- TECLens Donates 10,000 PPE Face Shields to Workers on Front Linehttps://modernod.com/news/teclens-donates-10000-ppe-face-shields-to-workers-on-front-line/2477543/TECLens announced the donation of 10,000 PPE face shields to the Montefiore Hospital System in Bronx, New York, for distribution to its hospitals’ frontline care givers. “Several weeks ago we established a dedicated network of 3D print makers to make face shield componen